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Reporting Checklist for Nature Neuroscience
This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. For more information, please  
read Reporting Life Sciences Research. 
 
Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the 
manuscript. 
 Statistics reporting, by figure
z  Please specify the following information for each panel reporting quantitative data, and where each item is reported (section, e.g. Results, & 
paragraph number). 

zEach figure legend should ideally contain an exact sample size (n) for each experimental group/condition, where n is an exact number and not a  
   range, a clear definition of how n is defined (for example x cells from x slices from x animals from x litters, collected over x days), a description of  
   the statistical test used, the results of the tests, any descriptive statistics and clearly defined error bars if applicable.  

z  For any experiments using custom statistics, please indicate the test used and stats obtained for each experiment.

z  Each figure legend should include a statement of how many times the experiment shown was replicated in the lab; the details of sample 
   collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader. 

z  For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number.
 
Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative.  
When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological 
process; it is misleading not to state this clearly.  
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 Representative figures
1.    Are any representative images shown (including Western blots and 
immunohistochemistry/staining) in the paper?  
If so, what figure(s)?
With the exception of Fig. 1, 3a, 7, Suppl. Fig. 4, 10, and 11, all 
figures show the results of individual sessions per panel, so in a 
sense all other figure show "representative" images. Reported 
significances were always calculated per session. Supplementary 
tables 1 and 3 give the results for all repetitions of the different 
experiments.
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2.    For each representative image, is there a clear statement of               
how many times this experiment was successfully repeated and a 
discussion of any limitations in repeatability?  
If so, where is this reported (section, paragraph #)?
Not explicitly; though we do make a point that the precise 
stimulation position is important and does explain a large part of 
the inter-session variance (see figure 3 and supplementary figure 
4), as well as Results paragraphs 5 and 11. Supplementary tables 1 
and 3 give the results for all repetitions of the different experiments 
and Supplementary figure 1 shows for all patches and subjects the 
results of individual experiments (together with average and 
standard error of the mean).
 Statistics and general methods
1.    Is there a justification of the sample size? 
If so, how was it justified?  
Where (section, paragraph #)?  
       Even if no sample size calculation was performed, authors should 
report why the sample size is adequate to measure their effect size. 
As customary in non-human-primate research we report data from 
two individuals. We report single-session data and assess the 
significance of the relevant comparisons also per session. Since the 
reported effect sizes are relatively large (up to a 90% change in 
percentage points) and hence reach statistical significance easily 
and the inter-session variance due to exact stimulation location was 
quite large, we feel justified in reporting single session data instead 
of averages which would "wash out" the location specificity of the 
reported results.
2.   Are statistical tests justified as appropriate for every figure?  
Where (section, paragraph #)?
Since we mainly compare contingency tables of correct and 
incorrect trials for different visual stimulus and electrical 
microstimulation conditions, we have the choice of chi-square and 
Fisher's exact test (FTE); since unlike the chi-square test, the FTE 
works with small, sparse, or unbalanced data as encountered when 
the performance approaches 100%, we used the FTE. See 
subsection "Data analysis" under the "Methods" section.
a.    If there is a section summarizing the statistical methods in 
the methods, is the statistical test for each experiment 
clearly defined? 
Yes. We always used Fisher's exact test, except for figure 3a and 
supplementary figure 4 were we report Pearson correlation results
b.   Do the data meet the assumptions of the specific statistical 
test you chose (e.g. normality for a parametric test)?  
Where is this described (section, paragraph #)?
The main assumption of Fisher's exact test,  independence of the 
rows and column classifications, were met by our experimental 
design in that we randomized the same percentage of trials for 
microstimulation for all experimental categories.
c.    Is there any estimate of variance within each group of  data?  
Is the variance similar between groups that are being 
statistically compared?  
Where is this described (section, paragraph #)?
Fisher's exact test works on contingency tables summarizing the 
number of correct and incorrect trials per condition, we did not 
calculate nor report variance estimates nor other descriptive 
statistics over all sessions (with the exception of supplementary 
figure 1 where we show all individual session results by subject and 
patch as well as the averages and standard error of the means, 
supplementary table 2 gives the number of sessions for each of the 
groups)
d.    Are tests specified as one- or two-sided? All Fisher's exact tests were specified as two-sided.
e.    Are there adjustments for multiple comparisons?  Since we only performed a pre-planned comparison between 
microstimulation and non-microstimulation trials inside each 
category (object identity times same-ness), or one test per 
condition no multiple comparison adjustments were required.
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3.    To promote transparency, Nature Neuroscience has stopped allowing 
bar graphs to report statistics in the papers it publishes. If you have 
bar graphs in your paper, please make sure to switch them to dot-
plots (with central and dispersion statistics displayed) or to box-and-
whisker plots to show data distributions.
The reported bar graphs in our paper are not showing summary 
statistics, so per bar there really is only one value and no associated 
dispersion. We believe and have confirmed with our editor that our 
bar graphs  follow the spirit of Nature Neuroscience's policy quite 
well.
4.    Are criteria for excluding data points reported?  
Was this criterion established prior to data collection?  
Where is this described (section, paragraph #)? 
 
We included all trials in which the animals did not break fixation 
before the the choice targets appeared.
5.    Define the method of randomization used to assign subjects (or 
samples) to the experimental groups and to collect and process data.   
If no randomization was used, state so.  
Where does this appear (section, paragraph #)?
We fully randomized trails with 50% probability into same and 
different identity trials. Electrical stimulation was delivered on 33% 
of trials (trials were grouped into groups of six; within these six 
trials, two had no microstimulation, while four had 
microstimulation 50% of the time, randomly chosen; we inserted 
the two non-microstimulation trials to maintain electrode integrity 
by avoiding long sequences of stimulation trials). 
The randomization procedure is described under Methods 
paragraph 5.
6.    Is a statement of the extent to which investigator knew the group 
allocation during the experiment and in assessing outcome included?   
If no blinding was done, state so.  
Where (section, paragraph #)?
No, not applicable.
7.    For experiments in live vertebrates, is a statement of compliance with 
ethical guidelines/regulations included?  
Where (section, paragraph #)?
Yes; section "Methods" first paragraph.
8.    Is the species of the animals used reported?  
Where (section, paragraph #)?
Yes, Rhesus macaque; section Methods second paragraph.
9.    Is the strain of the animals (including background strains of KO/
transgenic animals used) reported?  
Where (section, paragraph #)?
No. Not applicable.
10.    Is the sex of the animals/subjects used reported?  
Where (section, paragraph #)?
M1. M2 Yes, male; under section "Methods" paragraph 2. M3, M4 
also male not reported in text.
11.  Is the age of the animals/subjects reported?  
Where (section, paragraph #)?
No.
12.  For animals housed in a vivarium, is the light/dark cycle reported? 
Where (section, paragraph #)?
All animals were kept with a light cycle from 7:00 AM to 20:00 PM. 
Not reported in the main text.
Nature Neuroscience: doi:10.1038/nn.4527
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13.  For animals housed in a vivarium, is the housing group (i.e. number of 
animals per cage) reported? 
Where (section, paragraph #)?
All animals were pair-housed. Not reported in the main text.
14.  For behavioral experiments, is the time of day reported (e.g. light or 
dark cycle)?  
Where (section, paragraph #)?
Typically, experiments were performed in the light cycle during the 
period from 9:00AM to 20:00 PM. Not reported in the main text.
15.  Is the previous history of the animals/subjects (e.g. prior drug 
administration, surgery, behavioral testing) reported? 
Where (section, paragraph #)? 
 
No.
a.    If multiple behavioral tests were conducted in the same 
group of animals, is this reported? 
Where (section, paragraph #)?
No.
16.  If any animals/subjects were excluded from analysis, is this reported?  
Where (section, paragraph #)?
No animals were excluded from the analysis.
a.    How were the criteria for exclusion defined?  
Where is this described (section, paragraph #)?
Not applicable.
b.    Specify reasons for any discrepancy between the number of 
animals at the beginning and end of the study.   
Where is this described (section, paragraph #)?
Not applicable.
 Reagents
1.    Have antibodies been validated for use in the system under study 
(assay and species)? 
No.
a.    Is antibody catalog number given?  
Where does this appear (section, paragraph #)?
Not applicable.
b.    Where were the validation data reported (citation, 
supplementary information, Antibodypedia)?  
Where does this appear (section, paragraph #)?
Not applicable.
2.    Cell line identity 
                 a.     Are any cell lines used in this paper listed in the database of    
                         commonly misidentified cell lines maintained by ICLAC and  
                         NCBI Biosample?  
                  Where (section, paragraph #)?
No.
Nature Neuroscience: doi:10.1038/nn.4527
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b.    If yes, include in the Methods section a scientific 
justification of their use--indicate here in which section and 
paragraph the justification can be found.
Not applicable.
c.    For each cell line, include in the Methods section a 
statement that specifies: 
        - the source of the cell lines 
        - have the cell lines been authenticated? If so, by which   
          method? 
        - have the cell lines been tested for mycoplasma  
          contamination? 
Where (section, paragraph #)?
Not applicable.
 Data deposition
Provide a Data availability statement in the Methods section under "Data 
availability", which should include, where applicable: 
• Accession codes for deposited data 
• Other unique identifiers (such as DOIs and hyperlinks for any other 
datasets) 
• At a minimum, a statement confirming that all relevant data are 
available from the authors 
• Formal citations of datasets that are assigned DOIs 
• A statement regarding data available in the manuscript as source 
data 
• A statement regarding data available with restrictions 
    
See our data availability and data citations policy page for more 
information. 
   
Data deposition in a public repository is mandatory for: 
     a. Protein, DNA and RNA sequences 
     b. Macromolecular structures 
     c. Crystallographic data for small molecules 
     d. Microarray data 
Deposition is strongly recommended for many other datasets for which 
structured public repositories exist; more details on our data policy 
are available here. We encourage the provision of other source data 
in supplementary information or in unstructured repositories such as 
Figshare and Dryad. 
We encourage publication of Data Descriptors (see Scientific Data) to 
maximize data reuse.  
 Where is the Data Availability statement provided (section, paragraph 
#)? 
For all reported sessions (including those sessions that where only 
included in the regression analysis for Fig. 3 and Suppl. Fig 3 as 
Supplementary Tables 2; this table contains for each session the 
absolute numbers of hits and misses for all combinations of same/
different and microstimulation/no microstimulation. We believe 
that by including this data interested parties will be able to re-
analyze this data set in the future.
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 Computer code/software
Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable and readable form for readers at the 
time of publication. However, referees may ask for this information at any time during the review process.
 1.   Identify all custom software or scripts that were required to conduct 
the study and where in the procedures each was used.
All visual stimulation and behavioral control was performed using 
Shay Ohayon's Kofiko; electrode trajectory planning was performed 
using Shay Ohayon's Planner; see https://github.com/shayo for 
repositories of both. Data analysis was performed by custom 
matlab scripts.
2.   If computer code was used to generate results that are central to the 
paper's conclusions, include a statement in the Methods section 
under "Code availability" to indicate whether and how the code can 
be accessed. Include version information as necessary and any 
restrictions on availability.
All analysis was performed using standard statistics functions 
supplied as part of Matlab's toolboxes. Fisher's exact test was 
included as implemented by Giuseppe Cardillo 
 and distributed as https://www.mathworks.com/matlabcentral/
fileexchange/26883-myfisher
 Human subjects
1.    Which IRB approved the protocol?  
Where is this stated (section, paragraph #)?
Only non-human primates were used, no human subjects.
2.    Is demographic information on all subjects provided?  
Where (section, paragraph #)?
Not applicable.
3.    Is the number of human subjects, their age and sex clearly defined?  
Where (section, paragraph #)?
Not applicable.
4.    Are the inclusion and exclusion criteria (if any) clearly specified?  
Where (section, paragraph #)? 
Not applicable.
5.    How well were the groups matched?  
Where is this information described (section, paragraph #)?
Not applicable.
6.    Is a statement included confirming that informed consent was 
obtained from all subjects? 
Where (section, paragraph #)?
Not applicable.
7.    For publication of patient photos, is a statement included confirming 
that consent to publish was obtained? 
Where (section, paragraph #)?
Not applicable.
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 fMRI studies
For papers reporting functional imaging (fMRI) results please ensure that these minimal reporting guidelines are met and that all this 
information is clearly provided in the methods:
1.    Were any subjects scanned but then rejected for the analysis after the 
data was collected? 
No. In total four animals were scanned; two were used for the main 
experiments; the third was used to illustrate the effect of micro-
stimulation current on the volume of activated tissue; the fourth 
was used to elucidate the response of the face patches to 
abstracted and veridical house images.
a.    If yes, is the number rejected and reasons for rejection 
described?  
Where (section, paragraph #)?
Not applicable.
2.    Is the number of blocks, trials or experimental units per session and/
or subjects specified?  
Where (section, paragraph #)?
Except for the combined fMRI-microstim experiment in M3, we do 
not report the fMRI specifics as these have been reported in depth 
in our earlier papers cited; in M1 and M2 we only used fMRI to 
localize the face patches in each individual (for confirmation of 
stimulation locations we only used structural MRI); in M4 we 
localized the face patches as well as the responses to abstracted 
and veridical houses.
3.    Is the length of each trial and interval between trials specified? No. We always used simple blocked designes with on-off periods of 
around 30 seconds.
4.    Is a blocked, event-related, or mixed design being used? If applicable, 
please specify the block length or how the event-related or mixed 
design was optimized.
All fMRI  experiments were performed as blocked designs.
5.    Is the task design clearly described?  
Where (section, paragraph #)?
For localization experiments the animals were only required to keep 
fixation on a small fixation point on a screen, while passively viewing 
images presented centrally (diameter 5-7 degree visual angle). 
6.    How was behavioral performance measured? Fixation was controlled by an ISCAN eye tracker.
7.    Is an ANOVA or factorial design being used? No.
8.    For data acquisition, is a whole brain scan used?  
If not, state area of acquisition. 
Data for M1, M2, and M4 were acquired for the whole  brain. For 
M3 (figure 3) we used a field of view that contained the whole 
temporal lobe roughly centered around the stimulation electrode as 
the goal of this experiment was to compare the local spread of fMRI 
activation caused by different stimulation currents.
a.    How was this region determined? M3: FOV was centered around the stimulation cite to allow for the 
maximum possible activation spread in all directions
Nature Neuroscience: doi:10.1038/nn.4527
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9.  Is the field strength (in Tesla) of the MRI system stated? Yes, nominally 3Tesla, or 2.89362 Tesla as reported by the scanner.
a.    Is the pulse sequence type (gradient/spin echo, EPI/spiral) 
stated?
No, we used standard Siemens gradient echo EPI sequences with a 
isotropic voxelsize of 1.0 mm for M1, M2, and M4. Since we used 
the same localization system used in earlier studies we refer to 
those for details since nothing was changed. For M3 we used a 
voxelsize of 1.5 mm isotriopic, and a a multi-gradient echo EPI.
b.    Are the field-of-view, matrix size, slice thickness, and TE/TR/
flip angle clearly stated?
For M1, M2, and M4 see referenced papers. For M3 three a multi-
echo sequence (EPI, TR 4 s, TE 25 ms, 64 x 64 matrix, 28 slices at 1.5 
mm3 isotropic resolution 136 Volumes per run).  
10.  Are the software and specific parameters (model/functions, 
smoothing kernel size if applicable, etc.) used for data processing and 
pre-processing clearly stated?
Yes, all fMRI analysis was performed usig Fressurfer's fs-fast data 
processind stream.
11.  Is the coordinate space for the anatomical/functional imaging data 
clearly defined as subject/native space or standardized stereotaxic 
space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, 
paragraph #)?
For each animal we used a reference structural scan to which all 
other MRI-data (localizer fMRI data as well as per session structural 
MRI electrode position documentation data) was co-registered. We 
do not report group analysis results.
12.  If there was data normalization/standardization to a specific space 
template, are the type of transformation (linear vs. nonlinear) used 
and image types being transformed clearly described? Where (section, 
paragraph #)?
All registrations to each animal's reference structural data were 
performed as affine registrations. No inter-animal normalization 
was performed, since the goal of the localization experiments was 
to map the face patch system in each subject to allow electrode 
targeting.
13.  How were anatomical locations determined, e.g., via an automated 
labeling algorithm (AAL), standardized coordinate database (Talairach 
daemon), probabilistic atlases, etc.?
Face patches were individually localized for all four animals and the 
resulting 3-dimensional "maps" were the used for electrode 
trajectory planning and confirmation of documented stimulation 
positions.
14.  Were any additional regressors (behavioral covariates, motion etc) 
used?
We added regressors to control motion correlated signal and for 
localization experiments we excluded individual time points / TRs 
during which the animals did not fixate for at least 70% of the TR 
duration (to account for the delay in the HRF we accounted each 
fixation sample not at the actual measurement time, but shifted it 
by 2.4 seconds forward in time, the time it took the HRF to peak).
15.  Is the contrast construction clearly defined? No. We simply compared blocks in which we presented faces or 
houses with blocks in which we presented different categories of 
non-face non-house objects.
16.  Is a mixed/random effects or fixed inference used? We only performed analyses on the per-individual level.
a.    If fixed effects inference used, is this justified?
17.  Were repeated measures used (multiple measurements per subject)? No.
a.    If so, are the method to account for within subject 
correlation and the assumptions made about variance 
clearly stated?
Not applicable.
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18.  If the threshold used for inference and visualization in figures varies, is 
this clearly stated? 
The threshold for figure 1a, b is given in the legend, the threshold 
for supplementary figure 6 (threshold of 1.0000e-10 and a 
saturation value of 1.0000e-20 with 1.0000e-10 corresponding to 
<= 0.0005 Bonferroni corrected) is not specified in the text, but is 
the same threshold as used in figure 1b just with as as graded 
overlay to illustrate that the electrode tip ended in the core of the 
face patch (or rather on of the central voxels with really high 
significance). For Suppl. Fig. 7 we also used a threshold of 
1.0000e-10 corresponding to <= 0.0005 Bonferroni corrected. For 
Fig. 7 we report lower thresholds for M2. All fMRI  figures show the 
threshold and saturation points of the p-maps  in color scale bars in 
units of uncorrected negative decadic logarithm of p.
19.  Are statistical inferences corrected for multiple comparisons? The figure legend for figure 1a, b state the Bonferroni corrected 
threshold equivalent of the lower threshold.
a.    If not, is this labeled as uncorrected?
20.  Are the results based on an ROI (region of interest) analysis? For FIg. 7c and Suppl. Fig. 7c we report the average beta-value for 
individual face-patches.
a.    If so, is the rationale clearly described? Yes.
b.    How were the ROI’s defined (functional vs anatomical 
localization)? 
Face patch ROI's were based on localization fMRI mapping 
experiments in each individual monkey.
21.  Is there correction for multiple comparisons within each voxel? We only report uncorrected values in the figures. Based on the 
number of brain voxels per volume (M1, M2, M3 <= 174893 out of 
497664; M3 47641 out of 114688) the worst case Bonferroni 
correction 0.05/174893 will result in an uncorrected p <= 
2.8589e-07. So with the exception of Fig. 7 b) all reported overlay 
saturation values are well above the Bonferroni threshold for 0.05.
22.  For cluster-wise significance, is the cluster-defining threshold and the 
corrected significance level defined? 
No cluster-wise analysis was performed, but voxel-wise.
 Additional comments
     Additional Comments
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